Aug 13, 2026 08:00AM

Aug 4, 2026 09:01PM

Aug 4, 2026 09:00PM

Jul 28, 2026 07:03AM

Jul 28, 2026 07:00AM

Jun 18, 2026 08:00AM

Apr 23, 2026 01:13PM FDA issues complete response letter for Grace Therapeutics' GTx-104 drug

Apr 23, 2026 01:13PM

Apr 14, 2026 08:01AM

Apr 14, 2026 08:00AM

Mar 19, 2026 08:00AM

Feb 25, 2026 08:00AM

Feb 12, 2026 08:00AM

Nov 17, 2025 08:00AM Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference

Nov 13, 2025 08:00AM

Nov 11, 2025 08:30AM

Oct 23, 2025 08:02AM

Oct 23, 2025 08:00AM

Sep 22, 2025 08:01AM

Sep 22, 2025 08:00AM

Sep 18, 2025 08:31AM Grace Therapeutics receives sixth US patent for GTx-104 dosing regimen

Sep 18, 2025 08:30AM

Sep 4, 2025 08:00AM

Aug 27, 2025 08:00AM

Aug 12, 2025 08:00AM

Jun 25, 2025 08:03AM

Jun 25, 2025 08:00AM

Jun 23, 2025 08:00AM Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

Jun 13, 2025 08:00AM

Apr 9, 2025 08:04AM

Apr 9, 2025 08:00AM

Feb 25, 2025 08:00AM

Feb 18, 2025 06:48AM

Feb 13, 2025 08:00AM

Feb 10, 2025 08:05AM Grace Therapeutics (GRCE) Announces $30M Private Placement

Feb 10, 2025 08:05AM

Feb 10, 2025 08:04AM

Feb 10, 2025 08:01AM

Jan 7, 2025 08:00AM

Dec 4, 2024 08:00AM

Nov 13, 2024 08:00AM

Oct 30, 2024 08:00AM Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024

Oct 25, 2024 08:01AM

329,989 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All